Skip to content

Effects of Caffeine and Nicotine Gum on Balance Performance in Athletes

No Significant Alterations in Balance Performance After Acute Caffeine and Nicotine Gum Intake in Trained Athletes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07254832
Enrollment
20
Registered
2025-11-28
Start date
2024-01-08
Completion date
2024-07-02
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletic Performance, Healhty, Postural Stability

Keywords

Caffeinated chewing gum, Nicotine chewing gum, Caffeine, Nicotine, Dynamic balance, Postural control, Ellipse area, Perimeter length, Trained athletes

Brief summary

This randomized, single-blind, placebo-controlled, four-condition crossover study evaluates the acute effects of caffeine gum (\ 3 mg/kg) and nicotine gum (4 mg) on balance performance in healthy, trained adults. Each participant completes four test visits (caffeine gum, nicotine gum, xylitol-based placebo gum, and no-gum control) separated by ≥24 hours. Static and dynamic balance are assessed using the ProKin 252 system under standardized procedures. The primary outcomes are postural sway (ellipse area) and center-of-pressure path length over predefined test trials/time frames. The objective is to determine whether acute administration of these stimulants alters balance-related performance relative to placebo and control.

Detailed description

This study evaluates the acute effects of two commonly used stimulants-caffeine and nicotine administered in chewing-gum form-on static and dynamic balance performance in healthy, trained adults. The trial uses a randomized, single-blind, placebo-controlled, four-condition crossover design. Twenty participants complete four laboratory visits scheduled at the same time of day and separated by a washout interval of at least 24 hours. The order of the four conditions is randomized. Interventions are: (1) caffeine gum at approximately 3 mg/kg, (2) nicotine gum at 4 mg, (3) sugar-free xylitol-based placebo gum, and (4) a no-gum control condition. Pre-testing exposure is standardized across conditions: caffeine gum is chewed for 5 minutes, nicotine gum for 30 minutes, and placebo gum for 20 minutes prior to balance assessments. The control condition involves no gum exposure. All procedures are conducted under uniform laboratory conditions. Balance performance is assessed immediately after the pre-specified exposure period using the ProKin 252 balance platform. Standardized static and dynamic balance tasks are administered according to device guidelines and site procedures. Primary outcomes are postural sway quantified as ellipse area and center-of-pressure path length over predefined trials/time frames. Additional procedural details (e.g., task sequence, rest intervals, and device settings) are maintained in the study manual to ensure consistency across visits. The objective is to determine whether acute administration of caffeine or nicotine, relative to placebo and control, alters balance-related performance indices in healthy, physically active individuals.

Interventions

DIETARY_SUPPLEMENTCaffeine Gum 3mg/kg

Participants chewed 2-3 pieces of 100 mg caffeine gum (\ 3 mg/kg total) for 5 minutes prior to balance testing.

DIETARY_SUPPLEMENTNicotine Gum (4 mg)

Participants chewed one piece of 4 mg nicotine gum for 30 minutes before undergoing balance testing.

OTHERPlacebo Gum (Xylitol)

Participants chewed xylitol-based sugar-free gum with no active substance for 20 minutes prior to testing.

Sponsors

Gülbin Rudarlı
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

1. Be healthy, with no diagnosed neurological or musculoskeletal disorders 2. Be physically active and have at least 3 years of regular training history 3. Be between 18 and 30 years of age 4. Have no balance impairments or vestibular issues 5. Be non-smoker or not using tobacco during study days 6. Able to comply with the intervention protocols and attend all test sessions 7. Provide written informed consent

Exclusion criteria

1. Training age less than three years, 2. Having a disease or sports injury that will affect balance performance, 3. Using a drug or substance that affects balance, 4. Not being able to comply with or continue the study measurements.

Design outcomes

Primary

MeasureTime frameDescription
Static Postural Sway Ellipse Area - ProKin 252 Stabilometric PlatformAt each visit: 5 minutes after start of chewing (caffeine gum), 30 minutes after start of chewing (nicotine gum), 20 minutes after start of chewing (xylitol placebo gum), and 0 minutes (no gum) for the control condition; single 30-second trial per visitCenter of pressure (COP) 95% ellipse area during quiet bipedal stance (eyes open; standardized foot position) measured with the ProKin 252. Higher values indicate poorer balance. Unit of Measure: mm\^2

Secondary

MeasureTime frameDescription
Static Center of Pressure (COP) Path Length - ProKin 252 Stabilometric PlatformAt each visit: 5 minutes after start of chewing (caffeine gum), 30 minutes after start of chewing (nicotine gum), 20 minutes after start of chewing (xylitol placebo gum), and 0 minutes (no gum) for the control condition; single 30-second trial per visitTotal COP excursion length during quiet bipedal stance (eyes open; standardized foot position) measured with the ProKin 252. Higher values indicate poorer balance. Unit of Measure: mm

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026